https://www.business-standard.com/markets/news/cipla-rallies-4-on-usfda-approval-to-market-lanreotide-injection-124052200690_1.html
The approval for the generic version of Lanreotide Acetate is in line with Cipla's growth strategy in the complex product segment and will strengthen Cipla's...
us fda approvalciplaralliesmarketlanreotide